14 Jan 2026
// PRESS RELEASE
06 Jan 2026
// PRESS RELEASE
06 Jan 2026
// PRESS RELEASE
Latest Content by PharmaCompass
KEY PRODUCTS
Reset all filters
01 1Sodium hyaluronate, Intrinsic viscosity 1.28 m3/kg; 1.63 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use
02 1Sodium hyaluronate, Intrinsic viscosity 2.93 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use
Reset all filters
01 2KEWPIE CORP. Tokyo JP
Reset all filters
01 2Japan
Reset all filters
01 2Valid
Certificate Numbers : CEP 2018-037 - Rev 03
Status : Valid
Issue Date : 2025-03-26
Type : Chemical and TSE
Substance Number : 1472
Certificate Numbers : CEP 2019-064 - Rev 01
Status : Valid
Issue Date : 2025-07-09
Type : Chemical and TSE
Substance Number : 1472
Kewpie Corporation is a supplier offers 5 products (APIs, Excipients or Intermediates).
Find Sodium Hyaluronate bulk with DMF, CEP, JDMF offered by Kewpie Corporation
Find Sodium Hyaluronate bulk with DMF, JDMF offered by Kewpie Corporation
Find Hyaluronic Acid bulk with JDMF offered by Kewpie Corporation
Find Sodium Hyaluronate bulk with JDMF offered by Kewpie Corporation
Find Sodium Hyaluronate bulk offered by Kewpie Corporation